Once bound to HER2, DS-8201a is internalized into the endolysosomes and cleaved by lysosomal enzymes, including cathepsins B and L, which are highly expressed in tumour cells49–51, where deruxtecan is released. The gene discussed is ERBB2; the disease is neoplasm.